NeuroPace Inc (NPCE) stock forecast and price target
Price $7.56 · data as of November 13, 2026
12-month price target
Gold marker: average target · white marker: today’s price ($7.56)
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.41 | +38.0% | $91M |
| Next fiscal year ends December 31, 2027 | $-0.32 | +21.8% | $109M |
| Next quarter ends December 31, 2026 | $-0.14 | −71.7% | $23M |
| Quarter after ends March 31, 2027 | $-0.10 | — | $25M |
Consensus of the analysts covering NeuroPace, updated daily. In the last 30 days 7 estimates were raised and 0 lowered.
Our model vs. Wall Street
Analysts see 86.7% upside over 12 months. Our discounted cash flow model with moderate assumptions puts NeuroPace’s intrinsic value about 93% below today’s market value, and it scores 1.0 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the NeuroPace stock price target?
The average 12-month target from 9 analysts is $14.11, 86.7% above the current price of $7.56 Targets range from $7.00 to $22.00.
Is NeuroPace a buy according to analysts?
The consensus rating is “Buy” (6 buy, 4 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is NeuroPace expected to earn?
Analysts expect EPS of $-0.41 for the fiscal year ending December 31, 2026 and $-0.32 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.